Cancer colorectal markeri tumorali, Cat de credibili sunt markerii tumorali?
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation - ScienceDirect
Frontiers | Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer | npj Precision Oncology
Temporal course of serum tumor marker levels and radiologic tumor mass... | Download Scientific Diagram
Cancers | Free Full-Text | BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors | HTML
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine
Emerging actionable targets to treat therapy-resistant colorectal cancers
BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas in: European Journal of Endocrinology Volume 165 Issue 3 (2011)
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library
BRAF Gene Mutation Tests: Reference Range, Interpretation, Collection and Panels
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology
Frontiers | Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
Analize medicale - Markeri tumorali | Bioclinica
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases - Clinical Colorectal Cancer
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment - Annals of Oncology
Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation - ScienceDirect
Early differential responses elicited by BRAFV600E in adult mouse models | Cell Death & Disease
Cancers | Free Full-Text | Current Advances in the Treatment of BRAF-Mutant Melanoma | HTML
The MAPK signaling pathway (A) in a BRAF inhibitor-sensitive cell... | Download Scientific Diagram
Frontiers | The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
Histologic variants and rates of BRAF mutation. The percentage given... | Download Scientific Diagram
Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay | Scientific Reports
